Navigation Links
Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
Date:8/12/2008

EAST SETAUKET, N.Y., Aug. 12 /PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings, Inc. (OTC Bulletin Board: LIXT) announced today that it had filed a patent application for the use of compounds the company is developing for treatment of brain tumors as potential treatments for neurodegenerative diseases including Alzheimer's and Parkinson's Disease.

Dr. John S. Kovach, President and CEO of Lixte, said, "Lixte has developed a series of novel compounds that inhibit the growth of common brain cancers of adults and children in mouse models. We have now found that some variants of these compounds have effects on brain cells that are believed to be potentially useful for the treatment of common neurodegenerative brain diseases. Since Lixte is focused primarily on developing anti-cancer drugs, we are exploring partnerships with companies that have expertise and research programs in the treatment of Alzheimer's Disease."

About Lixte Biotechnology Holdings, Inc.:

Lixte Biotechnology Holdings, Inc. is a cancer therapeutics and diagnostics company. Founded as a biomarker-diagnostics company in 2005, Lixte develops new chemotherapy drugs targeting molecular abnormalities of common human cancers.

Forward-Looking Statements:

This announcement contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. For example, statements regarding the Company's financial position, business strategy and other plans and objectives for future operations, and assumptions and predictions about future product demand, supply, manufacturing, costs, marketing and pricing factors are all forward-looking statements. These statements are generally accompanied by words such as "intend," anticipate," "believe," "estimate," "potential(ly)," "continue," "forecast," "predict," "plan," "may," "will," "could," "would," "should," "expect" or the negative of such te
'/>"/>

SOURCE Lixte Biotechnology Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
2. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
3. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
4. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
5. Dr. Ari Kiev to be Featured Speaker at Biotechnology Conference Wall Street Unplugged: The Trout Group Investor Seminar in New York July 30
6. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
7. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
8. Genetic Engineering & Biotechnology News Reports on the Growing Role of Ion-Channel Studies in Global Biotech R&D
9. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
10. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
11. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2, 2015  Psychemedics Corporation (NASDAQ: PMD ), ... years, announced the addition of 2 new drugs to ... abuse concerns, the addition of Oxymorphone was made to ... as an option to the Amphetamine panel. ... "Sadly, more and more prescription drugs are being abused. ...
(Date:6/2/2015)... 2, 2015  Accuray Incorporated (Nasdaq: ARAY ), ... present at the Goldman Sachs 36th Annual Global Healthcare ... on Wednesday, June 10, 2015 at 4:00pm PT. ... will be available on the Investor Relations page of ... replay of the presentation will begin approximately one hour ...
(Date:6/2/2015)... , Minn. and WELLESLEY, Mass., June 2, 2015 /PRNewswire/ ... principal owner, Ampersand Capital Partners (Ampersand), announced the ... operation of Array BioPharma Inc. (Array).  Accuratus was ... Eagan, MN acquired Microtest ... GLP analytical and microbial testing services to the ...
Breaking Medicine Technology:Psychemedics Announces Addition Of FDA Cleared Drugs 2Psychemedics Announces Addition Of FDA Cleared Drugs 3Accuratus Lab Services Expands Capabilities with Acquisition of CMC Operation of Array BioPharma 2Accuratus Lab Services Expands Capabilities with Acquisition of CMC Operation of Array BioPharma 3
... NEW YORK, Oct. 25 2011 Help Remedies, the ... bold statement "Take Less", calling out big pharma for ... OTC drugs. In a category that traditionally promotes more, ... is communicating a unique message, that less – less ...
... 25, 2011 Reportlinker.com announces that a ... its catalogue: Global Eyeglasses ... This report analyzes the worldwide ... US$ Million by the following Product Segments: ...
Cached Medicine Technology:Help Remedies Suggests People TAKE LESS 2Help Remedies Suggests People TAKE LESS 3Global Eyeglasses Industry 2Global Eyeglasses Industry 3Global Eyeglasses Industry 4Global Eyeglasses Industry 5Global Eyeglasses Industry 6Global Eyeglasses Industry 7Global Eyeglasses Industry 8Global Eyeglasses Industry 9Global Eyeglasses Industry 10Global Eyeglasses Industry 11Global Eyeglasses Industry 12Global Eyeglasses Industry 13
(Date:6/2/2015)... OR (PRWEB) June 02, 2015 With ... dry in most parts of the United States, people ... conditioned rooms. Despite the obvious benefits of air conditioning, ... effects, including dry eye, dehydration and allergic reactions. Fresh ... Hour™ Power of Water® radio show, will discuss the ...
(Date:6/2/2015)... Bank, New Jersey (PRWEB) June 02, 2015 ... New Jersey’s largest nonprofit provider of home health ... appointment of its President and CEO, Steve Landers, ... America's (VNAA) Board of Directors. , VNAA ... that supports, promotes and advances mission driven, nonprofit ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Mercy Health ... serving Ohio and Kentucky – has devoted the seventh ... videos to skin cancer prevention. One in five Americans ... on Mercy Health’s YouTube channel, a Mercy Health expert ... are the main causes of skin cancer? , ...
(Date:6/2/2015)... 2015 First Choice Emergency Room ... in the United States, named Kenneth Alan Totz, D.O.as ... Road facility. , “We are pleased to announce ... facility,” said Dr. James M. Muzzarelli, Executive Medical Director ... received his undergraduate degree from St. Edwards University in ...
(Date:6/2/2015)... Phoenix, AZ (PRWEB) June 02, 2015 ... Iowa community, has granted $70,000 to the UNMC to support ... NFL Kicker Billy Cundiff, a member of the Colleen’s Dream ... grant was the biggest to date for Colleen’s Dream ... Dr. Wang in Omaha. , “Dr. Wang is a rising ...
Breaking Medicine News(10 mins):Health News:Air conditioning may contribute to dry eye, dehydration and allergies warns fresh water advocate Sharon Kleyne 2Health News:Air conditioning may contribute to dry eye, dehydration and allergies warns fresh water advocate Sharon Kleyne 3Health News:Steve Landers, MD, MPH, President and CEO of VNA Health Group Appointed to VNAA Board of Directors 2Health News:Steve Landers, MD, MPH, President and CEO of VNA Health Group Appointed to VNAA Board of Directors 3Health News:Video provides helpful information about skin cancer prevention 2Health News:First Choice Emergency Room Announces Dr. Kenneth Alan Totz as New Medical Director of Houston – Jones Road Facility 2Health News:Colleen’s Dream Foundation Grants $70,000 to the University of Nebraska Medical Center (UNMC) to Support Ovarian Cancer Research 2Health News:Colleen’s Dream Foundation Grants $70,000 to the University of Nebraska Medical Center (UNMC) to Support Ovarian Cancer Research 3
... participated in a cardiac-rehab program after a heart attack had ... the same age and sex who had not had a ... that occurred among patients in their study were due to ... involved about 1,800 patients. Nearly 60 percent participated in cardiac ...
... substantial morbidity and mortality and the incidence of MRSA ... to prevent the spread of MRSA including better hand ... the detection and isolation of infected patients. ... were done looking at reducing the spread of MRSA. ...
... reveals women suffering from extremely low body fat whether ... may benefit from treatment with the appetite-and-weight-regulation hormone ... in treating some instances of infertility. ,Leptin is ... stream, where it then travels to the brain and ...
... point to seek mental counseling. Experts say diabetics under ... because of unhealthy habits they implement to deal with ... showed nearly 13 percent of respondents experience psychological symptoms ... under mental distress are more likely than non-stressed diabetics ...
... recent study, a poor oral health diagnosis was a ... such as // high levels of fibrinogen (a clotting ... ,Researchers compared the oral health data of 256 ... characteristics. Results of the study show the strongest predictor ...
... new study shows consuming foods or supplements containing the omega-3 ... to avoid Alzheimer’s disease // even if you carry a ... study researchers first bred mice to carry the gene known ... various environmental factors affecting the symptoms were studied but the ...
Cached Medicine News:
Straight shafts with teeth and 5 mm tying platform. Wide serrated handle with polished finish. Teeth: 0.3 mm. Manufactured in titanium....
Serrated, 10 mm tips angled 90 degrees. Serrated cross action handle with polished finish....
Ergotec Vetriretinal Instrument System. Fine angled tips (3 mm). 20 gauge shaft length with black tip. Overall length from rear rotation knob to tip....
Ergotec Vetriretinal Instrument System. 2 mm pointed black tips with 0.6 mm platform. 20 gauge shaft tapers to 23 gauge....
Medicine Products: